Cytokinetics board
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 AM Eastern … Web2 days ago · Cytokinetics (CYTK) Dips 20% so Far in 2024 on Setbacks Cytokinetics (CYTK) declines 20% in the year so far as it suffers a regulatory setback for its NDA for omecamtiv mecarbil. 20h ago
Cytokinetics board
Did you know?
WebFeb 18, 2024 · Cytokinetics Names Muna Bhanji to Board of Directors Cytokinetics Names Muna Bhanji to Board of Directors Appointment Adds to Board Expertise in Commercial Development and Market Access... WebSep 26, 2012 · Stanford University professor James Spudich, one of the founders at MyoKardia, also was a co-founder of Cytokinetics, where he continues on a scientific advisory board. That all being said ...
WebFeb 27, 2024 · On Feb. 28, the FDA is set to decide on Cytokinetics ’ omecamtiv mecarbil (OM), a novel, selective cardiac myosin activator being evaluated for heart failure with reduced ejection fraction. The regulatory agency accepted the New Drug Application for OM in February 2024 and initially set a target action date of Nov. 30, 2024. WebJun 24, 2024 · SOUTH SAN FRANCISCO, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and …
WebDec 31, 2024 · CYTOKINETICS, INCORPORATED (Exact name of registrant as specified in its charter) (650) 624-3000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12 (b) of the Act: Securities registered pursuant to Section 12 (g) of the Act: None WebDescription. Developer of diagnostic therapeutics drug designed to improve the treatment of painful osteoarthritis, back, and joint pain. The company's drug offers a Fibronectin-Aggrecan Complex Test for molecular discography and a multi-analyte assay for diagnosing the source of pain in the spine and joints for identification of a naturally ...
WebLocation and Hours. By Appointment, 703-777-0236. Tuesdays from 1:00 p.m. to 4:30 p.m. 45201 Research Place. Suite 120. Ashburn, VA 20147. Please note that our walk-in …
WebNov 28, 2006 · Cytokinetics' unpartnered cardiovascular disease program is the second program to leverage the company's expertise in cytoskeletal pharmacology. Cytokinetics recently completed a Phase I clinical trial with CK-1827452, a novel small molecule cardiac myosin activator, and is advancing CK-1827452 in both intravenous and oral … phone no for fedexWebJan 7, 2024 · Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of Aficamten; Royalty Pharma Purchases Royalties on Future Sales of Aficamten; Cytokinetics to Host Conference Call and Webcast Today at 8:30 a.m. ET; NEW YORK, NY and SOUTH SAN FRANCISCO, … phone no for hmrc self assessment taxWebJun 23, 2024 · There were no plans to discuss CRT at the board meeting, according to Reuters reporter Gabriella Borter who reported from the meeting Tuesday evening. … how do you pronounce armeniaWebMar 29, 2024 · Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments ... how do you pronounce arrogantWebThis Amendment No. 6 to the Agreement (this “Amendment No. 6”) is entered into as of June 11, 2013 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a ... how do you pronounce arteritisWebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced changes to its Board of Directors. … how do you pronounce arrakisWebCytokinetics is led by a team of seasoned industry veterans with the shared objective to create the next great biopharmaceutical company that has the potential to change patients’ lives. With significant depth of industry experience and highly complementary … Vision 2024: Empowering Our Future. Vision 2025. Vision 2025: “Leading with … Robert has served as our President and Chief Executive Officer of Cytokinetics … Cytokinetics is a late-stage biopharmaceutical company focused on … how do you pronounce arrondissement